Skip to content

Redeemable NCI at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$2.14B-23.0%
UnitedHealth Group logo
UnitedHealth GroupUNH
$1.42B-67.3%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$58.8M+4.8%
Healthpeak Properties logo
Healthpeak PropertiesDOC
$27.21M+88.8%
McKesson logo
McKessonMCK
$943M

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.9B-49.1%
Enterprise value$6.77B-16.0%
P/S0.6×-0.6×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s redeemable nci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s redeemable NCI?
Surgery Partners, Inc. (SGRY) reported redeemable NCI of $383.4M in Q1 2026.
How has Surgery Partners, Inc.'s redeemable NCI changed year-over-year?
Surgery Partners, Inc.'s redeemable NCI decreased by 10.9% year-over-year, from $430.5M to $383.4M.
What is the long-term trend for Surgery Partners, Inc.'s redeemable NCI?
Over 5 years (2020 to 2025), Surgery Partners, Inc.'s redeemable NCI has grown at a 5.2% compound annual growth rate (CAGR), from $306.8M to $395.5M.
What does redeemable NCI mean?
Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.